SCHEMBL6687555

SCHEMBL6687555

Cn1c2ccccc2c2nnc(-n3nc(-c4ccc(Cl)cc4)cc3N)nc21

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 10/20 0.55
RAB9A P51151 5/20 0.55
NPC1 O15118 4/20 0.55
L3MBTL1 Q9Y468 2/20 0.55
KMT2A Q03164 7/20 0.52
MEN1 O00255 6/20 0.52
SMN1; SMN2 Q16637 5/20 0.52
KDM4E B2RXH2 3/20 0.52
ALDH1A1 P00352 7/20 0.49
LMNA P02545 4/20 0.49
HTT P42858 1/20 0.49
HIF1A Q16665 1/20 0.49
GAA P10253 3/20 0.45
STAT1 P42224 1/20 0.41
HCRTR1 O43613 1/20 0.40
CASP1 P29466 1/20 0.40
CASP7 P55210 1/20 0.40
TSHR P16473 2/20 0.40
GFER P55789 1/20 0.40
TP53 P04637 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6690846 0.91 RAB9A (0.60) MAPTRAB9ANPC1L3MBTL1KMT2A
SCHEMBL6687401 0.90 MAPT (0.55) MAPTRAB9ANPC1L3MBTL1KMT2A
SCHEMBL6686970 0.79 MAPT (0.74) MAPTRAB9ANPC1L3MBTL1KMT2A
SCHEMBL6688567 0.76 SMN1; SMN2 (0.50) MAPTRAB9ANPC1L3MBTL1KMT2A
SCHEMBL14366818 0.73 MAPT (0.71) MAPTRAB9ANPC1L3MBTL1KMT2A
SCHEMBL6687343 0.72 MAPT (1.00) MAPTRAB9ANPC1L3MBTL1KMT2A
SCHEMBL5606372 0.70 MAPT (0.65) MAPTRAB9ANPC1L3MBTL1KMT2A
SCHEMBL28358100 0.70 RAB9A (1.00) MAPTRAB9ANPC1L3MBTL1KMT2A
SCHEMBL24272316 0.69 MAPT (0.61) MAPTRAB9ANPC1L3MBTL1KMT2A
SCHEMBL14366837 0.68 MAPT (0.82) MAPTRAB9ANPC1L3MBTL1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2004096808-A1 TRIAZINE COMPOUNDS AND THEIR USE DE NOVO PHARMACEUTICALS LIMITED (GB) 2004-11-11 WO disclosed